Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Szkandera Joanna |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2023
Originalarbeit (Zeitschrift)
** Karner, C; Anders, I; Vejzovic, D; Szkandera, J; Scheipl, S; Deutsch, AJA; Weiss, L; Vierlinger, K; Kolb, D; Kühberger, S; Heitzer, E; Habisch, H; Zhang, F; Madl, T; Reininger-Gutmann, B; Liegl-Atzwanger, B; Rinner, B
Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines.
J Transl Med. 2023; 21(1): 54
Doi: 10.1186/s12967-022-03843-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rothermundt, C; Andreou, D; Blay, JY; Brodowicz, T; Desar, IME; Dileo, P; Gelderblom, H; Haas, R; Jakob, J; Jones, RL; Judson, I; Kunz, WG; Liegl-Atzwanger, B; Lindner, LH; Messiou, C; Miah, AB; Reichardt, P; Szkandera, J; van, der, Graaf, WTA; van, Houdt, WJ; Wardelmann, E; Hofer, S, , Writing, committee, on, behalf, of, CSSS, panellists
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022.
Eur J Cancer. 2022; 180:158-179
Doi: 10.1016/j.ejca.2022.11.008
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; Helmberg, W; Matzhold, EM; Barth, DA; Sareban, N; Szkandera, J; Liegl-Atzwanger, B; Leithner, A; Pichler, M
Impact of allogeneic red blood cell transfusion on prognosis in soft tissue sarcoma patients. A single-centre study.
Cancer Med. 2023; 12(2):1237-1246
Doi: 10.1002/cam4.4989
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; Kogler, A; Andreou, D; Scheipl, S; Bergovec, M; Castellani, C; Till, H; Benesch, M; Posch, F; Szkandera, J; Smolle-Jüttner, FM; Leithner, A
Prognostic Impact of Pulmonary Metastasectomy in Bone Sarcoma Patients: A Retrospective, Single-Centre Study.
Cancers (Basel). 2023; 15(6):
Doi: 10.3390/cancers15061733
PubMed
FullText
FullText_MUG
2022
Originalarbeit (Zeitschrift)
** Barth, DA; Stanzer, S; Spiegelberg, J; Bauernhofer, T; Absenger, G; Posch, F; Lipp, R; Halm, M; Szkandera, J; Balic, M; Gerger, A; Smolle, MA; Hutterer, GC; Klec, C; Jost, PJ; Kargl, J; Stradner, M; Pichler, M
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.
Cancer Med. 2022; 11(16):3074-3083
Doi: 10.1002/cam4.4675
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Barth, DA; Stanzer, S; Spiegelberg, JA; Bauernhofer, T; Absenger, G; Szkandera, J; Gerger, A; Smolle, MA; Hutterer, GC; Ahyai, SA; Madl, T; Posch, F; Riedl, JM; Klec, C; Jost, PJ; Kargl, J; Stradner, MH; Pichler, M
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.
Front Immunol. 2022; 13: 840207
Doi: 10.3389/fimmu.2022.840207
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bleckman, RF; Acem, I; van Praag, VM; Dorleijn, DMJ; Verhoef, C; Schrage, YM; Haas, RML; van de Sande, MAJ
Multimodality treatment of undifferentiated pleomorphic soft tissue sarcoma of the extremity (eUPS) in the elderly
EJSO-EUR J SURG ONC. 2022; 48(5): 985-993.
Doi: 10.1016/j.ejso.2021.12.008
Web of Science
PubMed
FullText
FullText_MUG
** Brcic, I; Scheipl, S; Bergovec, M; Leithner, A; Szkandera, J; Sotlar, K; Suda, A; Smolle, MA; Kraus, T; Rosenberg, AE; Liegl-Atzwanger, B; Igrec, J
Implementation of Copy Number Variations-Based Diagnostics in Morphologically Challenging EWSR1/FUS::NFATC2 Neoplasms of the Bone and Soft Tissue.
Int J Mol Sci. 2022; 23(24):
Doi: 10.3390/ijms232416196
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Seidel, MG; Kashofer, K; Moser, T; Thueringer, A; Liegl-Atzwanger, B; Leithner, A; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E
Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescents.
Front Pediatr. 2022; 10: 926405
Doi: 10.3389/fped.2022.926405
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; Musser, E; Bergovec, M; Friesenbichler, J; Wibmer, CL; Leitner, L; Sørensen, MS; Petersen, MM; Brcic, I; Szkandera, J; Scheipl, S; Leithner, A
Survival Prediction in Patients Treated Surgically for Metastases of the Appendicular Skeleton-An External Validation of 2013-SPRING Model.
Cancers (Basel). 2022; 14(14):
Doi: 10.3390/cancers14143521
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J
Keeping up the 'race pace' in a patient with nonuterine leiomyosarcoma
FUTURE ONCOL. 2022;
Doi: 10.2217/fon-2022-0636
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
2021
Originalarbeit (Zeitschrift)
** Brčić, I; Godschachner, TM; Bergovec, M; Igrec, J; Till, H; Lackner, H; Scheipl, S; Kashofer, K; Brodowicz, T; Leithner, A; Szkandera, J; Liegl-Atzwanger, B
Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
Mod Pathol. 2021; 34(2):396-407
Doi: 10.1038/s41379-020-00657-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mollnar, S; Pondorfer, P; Kasparek, AK; Reinisch, S; Moik, F; Stotz, M; Halm, M; Szkandera, J; Terbuch, A; Eisner, F; Gerger, A; Kapp, KS; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Stöger, H; Thurnher, D; Posch, F
Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy.
Clin Transl Oncol. 2021; 23(3):543-553
Doi: 10.1007/s12094-020-02447-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pink, D; Andreou, D; Bauer, S; Brodowicz, T; Kasper, B; Reichardt, P; Richter, S; Lindner, LH; Szkandera, J; Gruenwald, V; Kebenko, M; Kirchner, M; Hohenberger, P
Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient(R) in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)
CANCERS. 2021; 13(6): 1223
Doi: 10.3390/cancers13061223
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stoeger, H; Leithner, A; Heitzer, E; Liegl-Atzwanger, B; Szkandera, J
Molecular profiling of soft-tissue sarcomas with FoundationOne® Heme identifies potential targets for sarcoma therapy: a single-centre experience.
Ther Adv Med Oncol. 2021; 13:17588359211029125
Doi: 10.1177/17588359211029125
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Seeber, A; Weiss, L; Romeder, F; Szkandera, J; Kuehr, T; Kostner, S; Pichler, P; Jaeger, T; Kocher, F; Greil, R; Brodowicz, T
Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma : Data of real-world utilization in Austria.
Wien Klin Wochenschr. 2021; 133(1-2):21-25
Doi: 10.1007/s00508-019-01556-1
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; Herbsthofer, L; Goda, M; Granegger, B; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; El-Heliebi, A; Pichler, M; Gerger, A; Posch, F; Tomberger, M; López-García, P; Feichtinger, J; Baumgartner, C; Leithner, A; Liegl-Atzwanger, B; Szkandera, J
Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma.
Oncoimmunology. 2021; 10(1):1896658-1896658
Doi: 10.1080/2162402X.2021.1896658
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; Herbsthofer, L; Granegger, B; Goda, M; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; Pichler, M; Gerger, A; Rossmann, C; Riedl, J; Tomberger, M; López-García, P; El-Heliebi, A; Leithner, A; Liegl-Atzwanger, B; Szkandera, J
T-regulatory cells predict clinical outcome in soft tissue sarcoma patients: a clinico-pathological study.
Br J Cancer. 2021; 125(5):717-724
Doi: 10.1038/s41416-021-01456-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; van, de, Sande, M; Hayes, A; Bergovec, M; Smith, HG; Liegl-Atzwanger, B; Tunn, PU; Niethard, M; Windhager, R; Szkandera, J; Leithner, A, ;ESMO, Guidelines, Committee, EURACAN, and, GENTURIS
Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
Eur J Surg Oncol. 2021; 47(8): 2182-2188.
Doi: 10.1016/j.ejso.2021.03.252
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Woltsche, JN; Leithner, A; Smolle, MA; Szkandera, J; Maier, A; Liegl-Atzwanger, B; Smolle-Jüttner, FM
Late metastasis in Ewing sarcoma.
Pediatr Blood Cancer. 2021; 68(4):e28791-e28791
Doi: 10.1002/pbc.28791
Web of Science
PubMed
FullText
FullText_MUG
2020
Originalarbeit (Zeitschrift)
** Brčić, I; Brodowicz, T; Cerroni, L; Kashofer, K; Serbanescu, GL; Kasseroler, MT; Amann, G; Scheipl, S; Szkandera, J; Leithner, A; Liegl-Atzwanger, B
Undifferentiated round cell sarcomas with CIC-DUX4 gene fusion: expanding the clinical spectrum.
Pathology. 2020; 52(2):236-242
Doi: 10.1016/j.pathol.2019.09.015
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gilg, MM; Sunitsch, S; Leitner, L; Bergovec, M; Szkandera, J; Leithner, A; Liegl-Atzwanger, B
Tumor-associated mortality and prognostic factors in myxofibrosarcoma - A retrospective review of 109 patients.
Orthop Traumatol Surg Res. 2020; 106(6): 1059-1065.
Doi: 10.1016/j.otsr.2020.04.017
Web of Science
PubMed
FullText
FullText_MUG
** Klocker, EV; Barth, DA; Riedl, JM; Prinz, F; Szkandera, J; Schlick, K; Kornprat, P; Lackner, K; Lindenmann, J; Stöger, H; Stotz, M; Gerger, A; Pichler, M
Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.
Cancers (Basel). 2020; 12(5):
Doi: 10.3390/cancers12051154
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Klöckl, MC; Kasparek, AK; Riedl, JM; Moik, F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer, T; Schilcher, G; Zitta, S; Rosenkranz, AR; Friedl, C; Stöger, H; Posch, F
Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Sci Rep. 2020; 10(1):11219
Doi: 10.1038/s41598-020-68010-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; Sande, MV; Callegaro, D; Wunder, J; Hayes, A; Leitner, L; Bergovec, M; Tunn, PU; van Praag, V; Fiocco, M; Panotopoulos, J; Willegger, M; Windhager, R; Dijkstra, SPD; van Houdt, WJ; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Andreou, D; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J
Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models.
Cancers (Basel). 2019; 12(1):
Doi: 10.3390/cancers12010047
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; Schaffler, A; Leithner, A; Van, Praag, VM; Bergovec, M; Szkandera, J; Liegl-Atzwanger, B; Niethard, M; Tunn, PU; Van, De, Sande, M; Andreou, D
Incidence, treatment and outcome of abdominal metastases in extremity soft tissue sarcoma: Results from a multi-centre study.
J Surg Oncol. 2020; 121(4):605-611
Doi: 10.1002/jso.25856
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Stelzl, A; Aziz, F; Riedl, JM; Posch, F; Smolle, MA; Stojakovic, T; Terbuch, A; Pichler, M; Bergovec, M; Leithner, A; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Sourij, H; Szkandera, J
Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients.
Sci Rep. 2020; 10(1): 12438-12438.
Doi: 10.1038/s41598-020-69237-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Smolle, MA; Szkandera, J; Andreou, D; Palmerini, E; Bergovec, M; Leithner, A
Treatment options in unresectable soft tissue and bone sarcoma of the extremities and pelvis - a systematic literature review.
EFORT Open Rev. 2020; 5(11):799-814
Doi: 10.1302/2058-5241.5.200069
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Szkandera, J
The value of adoptive cell therapy and immunotherapy.
ONCOL RES TREAT. 2020; 43(SUPPL 4):10-10.-DGHO; OKT 09-12, 2021; Virtuell.
[Oral Communication]
Web of Science
2019
Originalarbeit (Zeitschrift)
** Barth, DA; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Stotz, M; Gerger, A
Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Clin Transl Oncol. 2019; 21(8):1034-1043
Doi: 10.1007/s12094-019-02037-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Callegaro, D; Miceli, R; Bonvalot, S; Ferguson, PC; Strauss, DC; van Praag, VVM; Levy, A; Griffin, AM; Hayes, AJ; Stacchiotti, S; Pèchoux, CL; Smith, MJ; Fiore, M; Tos, APD; Smith, HG; Catton, C; Szkandera, J; Leithner, A; van de Sande, MAJ; Casali, PG; Wunder, JS; Gronchi, A
Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors.
EClinicalMedicine. 2019; 17: 100215-100215.
Doi: 10.1016/j.eclinm.2019.11.008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lembeck, AL; Posch, F; Klocker, EV; Szkandera, J; Schlick, K; Stojakovic, T; Kornprat, P; Lackner, C; Gerger, A; Stoeger, H; Stotz, M; Pichler, M
Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
Clin Chem Lab Med. 2019; 57(5):740-744
Doi: 10.1515/cclm-2018-0016
Web of Science
PubMed
FullText
FullText_MUG
** Moik, F; Riedl, JM; Winder, T; Terbuch, A; Rossmann, CH; Szkandera, J; Bauernhofer, T; Kasparek, AK; Schaberl-Moser, R; Reicher, A; Prinz, F; Pichler, M; Stöger, H; Stotz, M; Gerger, A; Posch, F
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
Sci Rep. 2019; 9(1):5548
Doi: 10.1038/s41598-019-42069-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; van Praag, VM; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Riedl, JM; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Smolle-Jüttner, FM; Liegl-Atzwanger, B; Fiocco, M; van de Sande, MA; Leithner, A
Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methods.
Eur J Surg Oncol. 2019; 45(2):242-248
Doi: 10.1016/j.ejso.2018.06.019
Web of Science
PubMed
FullText
FullText_MUG
** Terbuch, A; Posch, F; Bauernhofer, T; Pichler, M; Peinsith, H; Szkandera, J; Riedl, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Stotz, M; Gerger, A
Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.
Anticancer Res. 2019; 39(10):5589-5596
Doi: 10.21873/anticanres.13753
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Scheipl, S; Liegl-Atzwanger, B; Szkandera, J; Rinner, B; Viertler, C; Friesenbichler, J; Bergovec, M; Leithner, A
[Is there a magic bullet for sarcomas? : Personalised treatment for maligant tumours of bone and soft tissue].
Orthopade. 2019; 48(9): 776-783.
Doi: 10.1007/s00132-019-03790-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Aziz, F; Stelzl, A; Riedl, J; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H
Diabetes is a predictor for survival in soft tissue sarcoma patients
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S477-S477.
[Poster]
Web of Science
** Aziz, F; Stelzl, A; Riedl, JM; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H
Association of serum glucose levels with disease free survival in soft tissue sarcoma patients
DIABETOLOGIA. 2019; 62: S562-S563.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN.
[Poster]
Web of Science
** Kocher, F; Seeber, A; Weiss, L; Romeder, F; Szkandera, J; Kuhr, T; Kostner, S; Pichler, P; Jager, T; Greil, R; Brodowicz, T
Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.
J CLIN ONCOL. 2019; 37(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 31-JUN 04, 2019; Chicago, IL.
[Poster]
Web of Science
** Szkandera, J
Which therapies for which molecular subtypes?
ONCOL RES TREAT. 2019; 42: 239-240.
Web of Science
2018
Originalarbeit (Zeitschrift)
** Asamer, E; Szkandera, J; Gibiser, P; Lembeck, AL; Stojakovic, T; Kornprat, P; Lackner, C; Winder, T; Schlick, K; Stöger, H; Gerger, A; Pichler, M; Stotz, M
Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.
Wien Klin Wochenschr. 2018; 130(19-20):569-574
Doi: 10.1007/s00508-018-1383-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Haas, RL; Szkandera, J
ASO Author Reflections: Benefit of Adjuvant Radiotherapy for Clinical Outcome in Patients with Soft Tissue Sarcoma.
ANN SURG ONCOL. 2018; 25(Suppl 3): 924-925.
Doi: 10.1245/s10434-018-6818-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Posch, F; Partl, R; Döller, C; Riedl, JM; Smolle, M; Leitner, L; Bergovec, M; Liegl-Atzwanger, B; Stotz, M; Bezan, A; Gerger, A; Pichler, M; Kapp, KS; Stöger, H; Leithner, A; Szkandera, J
Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study.
Ann Surg Oncol. 2018; 25(3):776-783
Doi: 10.1245/s10434-017-6080-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Posch, F; Silina, K; Leibl, S; Mündlein, A; Moch, H; Siebenhüner, A; Samaras, P; Riedl, J; Stotz, M; Szkandera, J; Stöger, H; Pichler, M; Stupp, R; van den Broek, M; Schraml, P; Gerger, A; Petrausch, U; Winder, T
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer.
Oncoimmunology. 2018; 7(2):e1378844-e1378844
Doi: 10.1080/2162402X.2017.1378844
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Terbuch, A; Adiprasito, JB; Stiegelbauer, V; Seles, M; Klec, C; Pichler, GP; Resel, M; Posch, F; Lembeck, AL; Stöger, H; Szkandera, J; Pummer, K; Bauernhofer, T; Hutterer, GC; Gerger, A; Stotz, M; Pichler, M
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Int J Mol Sci. 2018; 19(10):
Doi: 10.3390/ijms19103130
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Terbuch, A; Posch, F; Partl, R; Zurl, B; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Kapp, KS; Stöger, H; Gerger, A; Stotz, M
Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Cancer Med. 2018; 7(2):508-514
Doi: 10.1002/cam4.1317
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Leithner, A; van Praag, V; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Juttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stoger, H; Liegl-Atzwanger, B; Smolle, MA
Efficacy of metastasectomy on survival in patients with metachronous soft tissue sarcoma-metastasis: Results of a bi-centre study including 135 patients
ANN ONCOL. Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany. 2018; 29(S8):-43rd ESMO Congress (ESMO); OCT 19-23, 2018; Munich, GERMANY.
[Poster]
Web of Science
** Mollnar, S; Pondorfer, P; Reinisch, S; Moik, F; Halm, M; Kasparek, AK; Klockl, MC; Stotz, M; Szkandera, J; Gerger, A; Vasicek, S; Weiland, T; Pichler, M; Stoger, H; Thurnher, D; Posch, F
Definitive chemoradiotherapy with or without induction chemotherapy for unresectable squamous cell carcinoma of the head & neck: a propensity-score analysis
ONCOL RES TREAT. 2018; 41: 248-248.
[Poster]
Web of Science
** Smolle, MA; Tunn, PU; Goldenitsch, E; Posch, F; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B; Leithner, A
Outcome following unplanned excision in soft tissue sarcoma: Results of a multicentre study including 728 patients
ANN ONCOL. Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany. 2018; 29(S8):-43rd ESMO Congress (ESMO); OCT 19-23, 2018; Munich, GERMANY.
[Oral Communication]
Web of Science
Abstract (Konferenzband)
** Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F
Estimated versus measured glomerular filtration rate to
evaluate kidney function in patients with cancer undergoing
cisplatin-based chemotherapy
Oncology Research
and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Poster]
Web of Science
FullText
2017
Originalarbeit (Zeitschrift)
** Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M
Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.
PLoS One. 2017; 12(4):e0176283-e0176283
Doi: 10.1371/journal.pone.0176283
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heitzer, E; Sunitsch, S; Gilg, MM; Lohberger, B; Rinner, B; Kashofer, K; Stündl, N; Ulz, P; Szkandera, J; Leithner, A; Liegl-Atzwanger, B
Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.
Mod Pathol. 2017; 30(12):1698-1709
Doi: 10.1038/modpathol.2017.94
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Posch, F; Leitner, L; Bergovec, M; Bezan, A; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Leithner, A; Szkandera, J
Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Clin Orthop Relat Res. 2017; 475(5):1427-1435
Doi: 10.1007/s11999-017-5232-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Riedl, JM; Posch, F; Bezan, A; Szkandera, J; Smolle, MA; Winder, T; Rossmann, CH; Schaberl-Moser, R; Pichler, M; Stotz, M; Stöger, H; Gerger, A
Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.
BMC Cancer. 2017; 17(1):415-415
Doi: 10.1186/s12885-017-3392-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Riedl, JM; Posch, F; Moik, F; Bezan, A; Szkandera, J; Smolle, MA; Kasparek, AK; Pichler, M; Stöger, H; Stotz, M; Gerger, A
Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting.
Oncotarget. 2017; 8(56):96048-96061
Doi: 10.18632/oncotarget.21647
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; Andreou, D; Tunn, PU; Szkandera, J; Liegl-Atzwanger, B; Leithner, A
Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk.
EFORT Open Rev. 2017; 2(10):421-431
Doi: 10.1302/2058-5241.2.170005
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; Tunn, PU; Goldenitsch, E; Posch, F; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B; Leithner, A
The Prognostic Impact of Unplanned Excisions in a Cohort of 728 Soft Tissue Sarcoma Patients: A Multicentre Study.
Ann Surg Oncol. 2017; 24(6):1596-1605
Doi: 10.1245/s10434-017-5776-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Terbuch, A; Posch, F; Annerer, LM; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Gerger, A; Stotz, M
Long-term cardiovascular complications in stage I seminoma patients.
Clin Transl Oncol. 2017; 19(11):1400-1408
Doi: 10.1007/s12094-017-1742-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Smolle, MA; Leithner, A; Posch, F; Szkandera, J; Liegl-Atzwanger, B; Pichler, M
MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review.
Int J Mol Sci. 2017; 18(9):
Doi: 10.3390/ijms18091960
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J
ASCO update - what is new in the systemic treatment of advanced soft tissue sarcomas?
MEMO-MAG EUR MED ONC. 2017; 10(4): 233-236.
Doi: 10.1007/s12254-017-0346-0
Web of Science
FullText
FullText_MUG
Abstract (Zeitschrift)
** Bezan, A; Pasch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stager, H; Gerger, A; Stotz, M
Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J CLIN ONCOL. 2017; 35: -53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET; JUN 02-07, 2017; Chicago, IL.
Doi: 10.1200/JCO.2017.35.15_suppl.e16038
[Oral Communication]
Web of Science
FullText
FullText_MUG
2016
Originalarbeit (Zeitschrift)
** Kainhofer, V; Smolle, MA; Szkandera, J; Liegl-Atzwanger, B; Maurer-Ertl, W; Gerger, A; Riedl, J; Leithner, A
The width of resection margins influences local recurrence in soft tissue sarcoma patients.
Eur J Surg Oncol. 2016; 42(6):899-906
Doi: 10.1016/j.ejso.2016.03.026
Web of Science
PubMed
FullText
FullText_MUG
** Stotz, M; Liegl-Atzwanger, B; Posch, F; Mrsic, E; Thalhammer, M; Stojakovic, T; Bezan, A; Pichler, M; Gerger, A; Szkandera, J
Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.
PLoS One. 2016; 11(7):e0159448-e0159448
Doi: 10.1371/journal.pone.0159448
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wibmer, C; Amrein, K; Fahrleitner-Pammer, A; Gilg, MM; Berghold, A; Hutterer, GC; Maurer-Ertl, W; Gerger, A; Leithner, A; Pichler, M; Szkandera, J
Serum sclerostin levels in renal cell carcinoma patients with bone metastases.
Sci Rep. 2016; 6(4):33551-33551
Doi: 10.1038/srep33551
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M
An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK.
Doi: 10.1093/annonc/mdw371.77
[Poster]
Web of Science
FullText
FullText_MUG
2015
Originalarbeit (Zeitschrift)
** Reitz, D; Gerger, A; Seidel, J; Kornprat, P; Samonigg, H; Stotz, M; Szkandera, J; Pichler, M
Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer.
J Clin Pathol. 2015; 68(6):427-433
Doi: 10.1136/jclinpath-2014-202451
Web of Science
PubMed
FullText
FullText_MUG
** Stotz, M; Szkandera, J; Stojakovic, T; Seidel, J; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Seggewies, F; Hoefler, G; Gerger, A; Pichler, M
The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer.
Clin Chem Lab Med. 2015; 53(3):499-506
Doi: 10.1515/cclm-2014-0447
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Friesenbichler, J; Stojakovic, T; Leithner, A; Pichler, M
The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients.
Am J Surg. 2015; 210(1): 111-116.
Doi: 10.1016/j.amjsurg.2014.10.021
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Ploner, F; Stojakovic, T; Gary, T; Leithner, A; Pichler, M
Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients.
Clin Chem Lab Med. 2015; 53(3):493-497
Doi: 10.1515/cclm-2014-0486
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Herzog, S; Pichler, M; Stiegelbauer, V; Stotz, M; Schaberl-Moser, R; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Renner, W; Lenz, HJ; Berghold, A; Gerger, A
LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.
Pharmacogenomics J. 2015; 15(5):391-396
Doi: 10.1038/tpj.2015.2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Originalarbeit (Zeitschrift)
** Absenger, G; Benhaim, L; Szkandera, J; Zhang, W; Yang, D; Labonte, MJ; Pichler, M; Stotz, M; Samonigg, H; Renner, W; Gerger, A; Lenz, HJ
The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.
Pharmacogenomics J. 2014; 14(2):130-134
Doi: 10.1038/tpj.2013.15
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Friesenbichler, J; Leithner, A; Maurer-Ertl, W; Szkandera, J; Sadoghi, P; Frings, A; Maier, A; Andreou, D; Windhager, R; Tunn, PU
Surgical therapy of primary malignant bone tumours and soft tissue sarcomas of the chest wall: a two-institutional experience.
Int Orthop. 2014; 38(6):1235-1240
Doi: 10.1007/s00264-014-2304-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Friesenbichler, J; Sadoghi, P; Maurer-Ertl, W; Szkandera, J; Glehr, M; Ogris, K; Wolf, M; Weger, C; Leithner, A
Serum metal ion concentrations in paediatric patients following total knee arthroplasty using megaprostheses.
Biomed Res Int. 2014; 2014(6):817257-817257
Doi: 10.1155/2014/817257
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Glehr, M; Kaltenbach, A; Glehr, R; Sadoghi, P; Leithner, A; Gruber, G; Szkandera, J; Ludt, S; Vielgut, I; Glehr, R; Wensing, M
Physician awareness of knee and hip pain in the context of coronary heart disease treatment.
ScientificWorldJournal. 2014; 2014(4):494801-494801
Doi: 10.1155/2014/494801
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Stotz, M; Pichler, M; Absenger, G; Szkandera, J; Arminger, F; Schaberl-Moser, R; Samonigg, H; Stojakovic, T; Gerger, A
The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer.
Br J Cancer. 2014; 110(2):435-440
Doi: 10.1038/bjc.2013.785
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Stotz, M; Szkandera, J; Seidel, J; Stojakovic, T; Samonigg, H; Reitz, D; Gary, T; Kornprat, P; Schaberl-Moser, R; Hoefler, G; Gerger, A; Pichler, M
Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients.
PLoS One. 2014; 9(8):e104730-e104730
Doi: 10.1371/journal.pone.0104730
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Friesenbichler, J; Trajanoski, S; Stojakovic, T; Eberhard, K; Leithner, A; Pichler, M
The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas.
Int J Cancer. 2014; 135(2):362-370
Doi: 10.1002/ijc.28677
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Ploner, F; Stojakovic, T; Leithner, A; Pichler, M
Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.
PLoS One. 2014; 9(9):e107297-e107297
Doi: 10.1371/journal.pone.0107297
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Arminger, F; Weissmueller, M; Schaberl-Moser, R; Samonigg, H; Kornprat, P; Stojakovic, T; Avian, A; Gerger, A
The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients.
Am J Surg. 2014; 208(2):210-214
Doi: 10.1016/j.amjsurg.2013.10.030
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Weissmueller, M; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Winder, T; Renner, W; Gerger, A
A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients.
Clin Cancer Res. 2014; 20(6):1687-1697
Doi: 10.1158/1078-0432.CCR-13-1517
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Pichler, M; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Ploner, F; Stojakovic, T; Samonigg, H; Eberhard, K; Leithner, A; Gerger, A
The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
J Surg Oncol. 2014; 109(2):139-144
Doi: 10.1002/jso.23458
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Stotz, M; Absenger, G; Stojakovic, T; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Alzoughbi, W; Lackner, C; Ress, AL; Seggewies, FS; Gerger, A; Hoefler, G; Pichler, M
Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients.
Br J Cancer. 2014; 110(1):183-188
Doi: 10.1038/bjc.2013.701
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Originalarbeit (Zeitschrift)
** Absenger, G; Szkandera, J; Pichler, M; Stotz, M; Arminger, F; Weissmueller, M; Schaberl-Moser, R; Samonigg, H; Stojakovic, T; Gerger, A
A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.
Br J Cancer. 2013; 109(2):395-400
Doi: 10.1038/bjc.2013.346
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Absenger, G; Szkandera, J; Stotz, M; Pichler, M; Winder, T; Langsenlehner, T; Langsenlehner, U; Samonigg, H; Renner, W; Gerger, A
A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
Mol Carcinog. 2013; 52 Suppl 1(9):E96-102
Doi: 10.1002/mc.22028
Web of Science
PubMed
FullText
FullText_MUG
** Absenger, G; Szkandera, J; Stotz, M; Postlmayr, U; Pichler, M; Ress, AL; Schaberl-Moser, R; Loibner, H; Samonigg, H; Gerger, A
Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.
Anticancer Res. 2013; 33(10):4591-4594
Web of Science
PubMed
** Ploner, F; Lamm, W; Schur, S; Eisterer, W; Kühr, T; Lindorfer, A; Tinchon, C; Köstler, WJ; Szkandera, J; Brodowicz, T
The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS).
J Cancer Res Clin Oncol. 2013; 139(8):1337-1342
Doi: 10.1007/s00432-013-1447-8
Web of Science
PubMed
FullText
FullText_MUG
** Stotz, M; Eisner, F; Szkandera, J; Absenger, G; Kornprat, P; Lackner, C; Samonigg, H; Gerger, A; Pichler, M
Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series.
J Clin Pathol. 2013; 66(9):753-757
Doi: 10.1136/jclinpath-2012-201394
Web of Science
PubMed
FullText
FullText_MUG
** Stotz, M; Gerger, A; Eisner, F; Szkandera, J; Loibner, H; Ress, AL; Kornprat, P; AlZoughbi, W; Zoughbi, WA; Seggewies, FS; Lackner, C; Stojakovic, T; Samonigg, H; Hoefler, G; Pichler, M
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer.
Br J Cancer. 2013; 109(2):416-421
Doi: 10.1038/bjc.2013.332
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Stotz, M; Gerger, S; Zacherl, M; Renner, W; Haijun, M; Leithner, A; Gerger, A
Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients.
Cancer Epidemiol. 2013; 37(6):1003-1009
Doi: 10.1016/j.canep.2013.10.003
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Stotz, M; Samonigg, H; Glehr, M; Zacherl, M; Stojakovic, T; Gerger, A; Leithner, A
Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.
Br J Cancer. 2013; 108(8):1677-1683
Doi: 10.1038/bjc.2013.135
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Absenger, G; Pichler, M; Stotz, M; Langsenlehner, T; Samonigg, H; Renner, W; Gerger, A
Association of common gene variants in vitamin D modulating genes and colon cancer recurrence.
J Cancer Res Clin Oncol. 2013; 139(9):1457-1464
Doi: 10.1007/s00432-013-1461-x
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Samonigg, H; Maurer-Ertl, W; Stojakovic, T; Ploner, F; Leithner, A; Pichler, M
Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients.
Br J Cancer. 2013; 109(9):2316-2322
Doi: 10.1038/bjc.2013.595
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Stotz, M; Eisner, F; Absenger, G; Stojakovic, T; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Alzoughbi, W; Ress, AL; Seggewies, FS; Gerger, A; Hoefler, G; Pichler, M
External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.
PLoS One. 2013; 8(11):e78225-e78225
Doi: 10.1371/journal.pone.0078225
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Winder, T; Stotz, M; Weissmueller, M; Langsenlehner, T; Pichler, M; Samonigg, H; Renner, W; Gerger, A; Absenger, G
A common gene variant in PLS3 predicts colon cancer recurrence in women.
Tumour Biol. 2013; 34(4):2183-2188
Doi: 10.1007/s13277-013-0754-7
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Szkandera, J; Kiesslich, T; Haybaeck, J; Gerger, A; Pichler, M
Hedgehog signaling pathway in ovarian cancer.
Int J Mol Sci. 2013; 14(1):1179-1196
Doi: 10.3390/ijms14011179
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Korrektur
** Stotz, M; Gerger, A; Eisner, F; Szkandera, J; Loibner, H; Ress, AL; Kornprat, P; Alzoughbi, W; Seggewies, FS; Lackner, C; Stojakovic, T; Samonigg, H; Hoefler, G; Pichler, M
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable as well as inoperable pancreatic cancer.
Br J Cancer. 2013; 109(7): 2026-2026.
Doi: 10.1038/bjc.2013.591
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kommentar
** Szkandera, J; Pichler, M; Gerger, A; Leithner, A
Reply: Comment on 'Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients'
Br J Cancer. 2013; 108(12):2627-2627
Doi: 10.1038/bjc.2013.276
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Pichler, M; Stotz, M; Gerger, A
Reply: comment on 'A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients'.
Br J Cancer. 2013; 109(12):3126-3127
Doi: 10.1038/bjc.2013.599
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Originalarbeit (Zeitschrift)
** Szkandera, J; Absenger, G; Dandachi, N; Regitnig, P; Lax, S; Stotz, M; Samonigg, H; Renner, W; Gerger, A
Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Mol Genet Genomics. 2012; 287(9):755-764
Doi: 10.1007/s00438-012-0715-7
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Absenger, G; Stotz, M; Weissmueller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A
The Functional Polymorphism of Erythropoietin Gene rs1617640 G>T Is Not Associated with Susceptibility and Clinical Outcome of Early-stage Breast Cancer.
Anticancer Res. 2012; 32(8):3473-3478
Web of Science
PubMed
Abstract (Zeitschrift)
** Absenger, G; Szkandera, J; Weissmuller, M; Postlmayr, U; Pichler, M; Loibner, H; Samonigg, HS; Gerger, A;
The preoperative neutrophil to lymphocyte ratio predicts disease-free survival and overall survival in patients with stage II and III colon cancer.
ONKOLOGIE. ONKOLOGIE35: 55-56. BASEL: KARGER;
[Poster]
Web of Science
** Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Gerger, A; Kielhauser, S; Absenger, G; Szkandera, J; Samonigg, H; Krippl, P; Renner, W;
COMMON VEGF GENE POLYMORPHISMS ARE NOT ASSOCIATED WITH RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS.
ANN ONCOL. 2012; 23: 86-87.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN.
[Poster]
Web of Science
** Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Gerger, A; Kielhauser, S; Thurner, E-M; Absenger, G; Szkandera, J; Samonigg, H; Glehr, M; Krippl, P; Renner, W
Genetic variants of UGT1A4 and their impact on relapse-free survival in Tamoxifen treated breast cancer patients.
Onkologie. 2012; 35(S 6):64-64.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgart, GERMANY.
[Poster]
Web of Science
** Szkandera, J; Absenger, G; Dandachi, N; Regitnig, P; Lax, S; Stotz, M; Winder, T; Samonigg, H; Renner, W; Gerger, A
Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575.
[Poster]
Web of Science
** Szkandera, J; Absenger, G; Stotz, M; Weissmuller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A
The functional polymorphism of erythropoietin gene rs1617640 G > T is not associated with susceptibility and clinical outcome of early-stage breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575.
[Poster]
Web of Science
** Szkandera, J; Winder, T; Absenger, G; Stotz, M; Weissmuller, M; Langsenlehner, T; Hofmann, G; Samonigg, H; Renner, W; Gerger, A;
A COMMON GENE VARIANT IN PLS3 PREDICTS COLON CANCER RECURRENCE IN WOMEN.
ANN ONCOL. 2012; 23: 83-83.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN.
[Poster]
Web of Science
** Thurner, EM; Krenn-Pilko, S; Renner, W; Szkandera, J; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T;
Role of Polymorphisms in the ERCC2 Gene in the Development of Severe Side Effects After Radiotherapy of Prostate Cancer Patients.
EUR J CANCER. EUROPEAN JOURNAL OF CANCER48: S271-S271. OXFORD: ELSEVIER SCI LTD; ( Presented at: 22nd Biennial Congress of the European-Association-for-Cancer-Research, Barcelona, SPAIN, JUL 07-10, 2012)
Doi: 10.1016/S0959-8049(12)71727-6
[Poster]
Web of Science
FullText
FullText_MUG
2011
Originalarbeit (Zeitschrift)
** Balic, M; Rapp, N; Stanzer, S; Lin, H; Strutz, J; Szkandera, J; Daidone, MG; Samonigg, H; Cote, RJ; Dandachi, N
Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells.
Appl Immunohistochem Mol Morphol. 2011; 19(1):33-40
Doi: 10.1097/PAI.0b013e3181ebf4e8
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Hofmann, G; Langsenlehner, U; Langsenlehner, T; Glehr, M; Gerger, A; Absenger, G; Szkandera, J; Fuerst, F; Samonigg, H; Krippl, P; Renner, W
Single nucleotide polymorphisms of integrin alpha-2 and beta-3 genes are not associated with relapse-free and overall survival in colorectal cancer patients.
Anticancer Res. 2011; 31(4):1373-1377
Web of Science
PubMed
Abstract (Zeitschrift)
** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Absenger, G; Samonigg, H; Krippl, P; Renner, W
A COMMON HEREDITARY SINGLE NUCLEOTIDE POLYMORPHISM IN THE IN THE GENE OF DEATH RECEPTOR 4 (TNFRSF10A) AND ITS IMPACT ON OVERALL SURVIVAL IN RECTAL CANCER PATIENTS
ANN ONCOL. . 2011; 22: v129-v129.-ESMO 13th World Congress on Gastrointestinal Cancer; JUN 22-25, 2011; Barcelona, SPAIN.
[Poster]
Web of Science
** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Absenger, G; Samonigg, H; Krippl, P; Renner, W
Common single nucleotide polymorphisms in the genes of integrin alpha-2 and beta-3 subunits are not associated with overall survival in rectal cancer patients
ONKOLOGIE. 2011; 34: 245-246.-Gemeinsame Jahrestagung 2011 der DGHO, ÖGHO, SGMO und SGH+SSH; SEP 30-OCT 4, 2011; Basel, SWITZERLAND.
[Poster]
Web of Science
2010
Originalarbeit (Zeitschrift)
** Gerger, A; Renner, W; Langsenlehner, T; Hofmann, G; Knechtel, G; Szkandera, J; Samonigg, H; Krippl, P; Langsenlehner, U
Association of interleukin-10 gene variation with breast cancer prognosis.
Breast Cancer Res Treat. 2010; 119(3):701-705
Doi: 10.1007/s10549-009-0417-y
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Knechtel, G; Hofmann, G; Gerger, A; Renner, W; Langsenlehner, T; Szkandera, J; Wolf, G; Samonigg, H; Krippl, P; Langsenlehner, U
Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer.
J Cancer Res Clin Oncol. 2010; 136(12):1813-1819
Doi: 10.1007/s00432-010-0839-2
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Knechtel, G; Stoeger, H; Szkandera, J; Dorr, K; Beham, A; Samonigg, H
Desmoid tumor treated with polychemotherapy followed by imatinib: a case report and review of the literature.
Case Rep Oncol. 2010; 3(2): 287-293.
Doi: 10.1159/000318873
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Knechtel, G; Szkandera, J; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Samonigg, H; Renner, W; Langner, C; Dehchamani, D; Gerger, A
Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk.
Mol Carcinog. 2010; 49(9):805-809
Doi: 10.1002/mc.20655
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Knechtel, G; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Langsenlehner, T; Dehchamani, D; Samonigg, H; Renner, W; Gerger, A
Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis.
Anticancer Res. 2010; 30(6):2393-2397
Web of Science
PubMed
Google Scholar
** Szkandera, J; Ploner, F; Bauernhofer, T; Kasparek, AK; Payer, F; Balic, M; Knechtel, G; Gerger, A; Gallè, G; Samonigg, H; Hofmann, G
Paraneoplastic limbic encephalitis in a patient with extragonadal choriocarcinoma--significance of onconeural antibodies.
Onkologie. 2010; 33(8-9):452-454
Doi: 10.1159/000317269
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Hofmann, G; Langsenlehner, T; Fuerst, F; Szkandera, J; Gerger, A; Langsenlehner, U; Krippl, P; Renner, W
Association of a single nucleotide polymorphism in the gene of TNFRSF10A (TRAILR-1) with relapse-free survival in colorectal cancer.
Onkologie2010; 33(S 6):173-173.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 1-5, 2010; Berlin, GERMANY. (ISBN: 0378-584X )
[Poster]
Web of Science
** Knechtel, G; Szkandera, J; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Samonigg, H; Renner, W; Dehchamani, D; Gerger, A
Single nucleotide polymorphisms in the hypoxia-inducible factor 1 gene and colorectal cancer risk
Onkologie-International Journal for Cancer Research and Treatment2010; 33(S6):225-226.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 1-5, 2010; Berlin, GERMANY. (ISBN: 978-3-8055-9633-6 )
[Oral Communication]
Web of Science
** Szkandera, J; Knechtel, G; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Langsenlehner, T; Dehchamani, D; Samonigg, H; Renner, W; Gerger, A
Association of Hypoxia Inducible Factor 1-alpha Gene Polymorphisms and Colorectal Cancer Prognosis.
Onkologie-International Journal for Cancer Research and Treatment2010; 33(S6):226-226.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 1-5, 2010; Berlin, GERMANY. (ISBN: 978-3-8055-9633-6 )
[Oral Communication]
Web of Science
2009
Originalarbeit (Zeitschrift)
** Richtig, E; Gerger, A; El-Shabrawi-Caelen, L; Szkandera, J; Hofmann-Wellenhof, R
Reflectance confocal microscopy in early diagnosis of cutaneous metastases of breast cancer.
Gynecol Oncol. 2009; 115(3):510-511
Doi: 10.1016/j.ygyno.2009.08.030
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Knechtel, G; Szkandera, J; Krippl, P; Renner, W
The 683A>C polymorphism in the ligand binding domain of TRAILR-1 (TNFRSF10A) is not associated with colorectal cancer survival.
Annals of Oncology2009; 20(S 7):31-31.-11th World Congress on Gastrointestinal Cancer ; JUNE 24-27, 2009; Barcelona, SPAIN.
[Poster]
Web of Science